Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation
Most trials on mRNA vaccines against SARS-CoV-2 did not include patients with chronic kidney disease (CKD), hemodialysis (HD) patients, or kidney transplant recipients (KTR). However, those patients have a higher risk for a severe course of COVID-19 disease and mortality. Available literature has de...
Main Authors: | Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, Markus Pirklbauer, Michael Rudnicki, Gert Mayer, Julia Kerschbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/1/148 |
Similar Items
-
Humoral Immune Response to a Timely Booster mRNA Vaccination in Non-Responders to a Standard Vaccination Schedule against COVID-19 in Kidney Transplant Recipients
by: Julia Stigler, et al.
Published: (2022-10-01) -
Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS)
by: Sebastian Sallaberger, et al.
Published: (2022-12-01) -
Covid-19 in Egyptian hemodialysis and kidney transplant children: retrospective analysis of single center experience
by: Fatina I. Fadel, et al.
Published: (2022-08-01) -
Depression Among Chronic Kidney Diseases Patients Receiving Hemodialysis
by: Shanti Khadka, et al.
Published: (2020-12-01) -
The Natural Course of Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease undergoing Hemodialysis
by: Ye Na Kim, et al.
Published: (2021-12-01)